Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Stereotactic Radiosurgery

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Recruiting1
Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07066475RecruitingPrimary

A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach

NCT05179824Active Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT00185666Phase 1/2CompletedPrimary

Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Showing all 3 trials

Research Network

Common Treatments

  • Stereotactic Radiosurgery1
  • Observation1

Active Sponsors

  • Tempus AI1
  • Beijing Tiantan Hospital1
  • Stanford University1

Top Investigators

Related Conditions

  • Cancer Of Colon1
  • Cancer Of Cervix1
  • Cancer Of Rectum1
  • Cancer Of Stomach1
  • Cancer Of Skin1

Activity Timeline